Patents by Inventor The United States of America, as represented by the Secretary, Dept. of Health and Human Services

The United States of America, as represented by the Secretary, Dept. of Health and Human Services has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130198214
    Abstract: The present subject matter relates to a personalized weight management program incorporating dynamic feedback control using a validated mathematical model of metabolism and weight change. In general, the subject matter provides a system for repeated monitoring of one or more parameters such as, for example, body weight, physical activity, diet, eating behavior, or various other physiological and behavioral measurements, and using the parameter(s) to calculate an objective and personalized measure of adherence to a prescribed intervention, iteratively update mathematical model parameters, and adjust the prescribed intervention based on revised model predictions. Such a dynamic feedback control methodology can improve adherence to weight management interventions and result in greater weight loss and improved weight maintenance. The present subject matter also relates to a novel, cost-effective, weight management tool that could be widely disseminated through the internet and mobile computing platforms.
    Type: Application
    Filed: January 30, 2013
    Publication date: August 1, 2013
    Inventor: The Government of the United State of America, as represented by the Secretary, Dept of Health and Human Services
  • Publication number: 20130023506
    Abstract: The invention relates to a method for treating uterine fibroids, which method comprises administering to a patient in need thereof, an effective amount of 17?-acetoxy-11?-[4-N,N-dimethylamino-phenyl)-19-norpregna-4,9-diene-3,20-dione (ulipristal) or any metabolite thereof. More particularly, the method is useful for reducing or stopping bleeding in a patient afflicted with uterine fibroids, and/or for reducing the size of uterine fibroids.
    Type: Application
    Filed: September 19, 2012
    Publication date: January 24, 2013
    Applicants: The United States of America, as represented by the Secretary, Dept. of Health and Human Services, Laboratoire HRA-PHARMA
    Inventors: Laboratoire HRA-PHARMA, The United States of America, as represented by the Secretary, Dept. of Health and Human Services